Healthcare delivery via telehealth during the COVID-19 pandemic: The experience of a Huntington's disease clinic.
Healthcare delivery via telehealth during the COVID-19 pandemic: The experience of a Huntington's disease clinic.
复制标题
DOI：
10.1016/j.prdoa.2021.100093
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Gonzalez-Alegre P
中科院分区：
文献类型：
--
作者：
Klapper J;Bardakjian T;Sigal I;Muralidharan K;Gonzalez-Alegre P
Jennifer Klapper 没有需要披露的潜在利益冲突。 Tanya Bardakjian 没有需要披露的潜在利益冲突。 Ian Sigal 没有需要披露的潜在利益冲突。 Kavitha Muralidharan 没有需要披露的潜在利益冲突。 Pedro Gonzalez-Alegre 已从 Eisai Therapeutics、Spark Therapeutics 和 NeuExcell Therapeutics 获得咨询费。
Jennifer Klapper has no potential conflicts of interest to disclose. Tanya Bardakjian has no potential conflicts of interest to disclose. Ian Sigal has no potential conflicts of interest to disclose. Kavitha Muralidharan has no potential conflicts of interest to disclose. Pedro Gonzalez-Alegre has received consulting fees from Eisai Therapeutics, Spark Therapeutics and NeuExcell Therapeutics.
影响因子：
3.1
作者：
Bardakjian, Tanya M.;Klapper, Jennifer;Gonzalez-Alegre, Pedro
通讯作者：
Gonzalez-Alegre, Pedro
影响因子：
3.5
作者：
Hawkins, A. K.;Creighton, S.;Hayden, M. R.
通讯作者：
Hayden, M. R.
影响因子：
3.1
作者：
Bull, Michael T.;Darwin, Kristin;Biglan, Kevin M.
通讯作者：
Biglan, Kevin M.